Sodium and fluid management in acute brain injury

Current Neurology and Neuroscience Reports

Volumn 12, Issue 4, 2012, Pages 466-473

  Wright, Wendy L ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Acute brain injury; Cerebral edema; Cerebral salt wasting syndrome; Dysnatremia; Fluid management; Hypernatremia; Hyponatremia; Neurocritical care; Osmotherapy; Sodium; Sodium modulation; Syndrome of inappropriate antidiuresis; Therapeutic hypernatremia; Vasopressin receptor antagonists

Indexed keywords

CONIVAPTAN; DESMOPRESSIN ACETATE; DIURETIC AGENT; FLUDROCORTISONE; FUROSEMIDE; HYPOTONIC SOLUTION; INFUSION FLUID; MANNITOL; SODIUM; SODIUM CHLORIDE; TOLVAPTAN; VASOPRESSIN;

ARTICLE; BRAIN EDEMA; BRAIN INJURY; BRAIN PERFUSION; CEREBRAL SALT WASTING; DIABETES INSIPIDUS; DRUG EFFECT; FLUID BALANCE; HUMAN; HYPERNATREMIA; HYPONATREMIA; HYPOVOLEMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INTRACRANIAL PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; OSMOTIC PRESSURE; PRACTICE GUIDELINE; SODIUM BALANCE; SODIUM BLOOD LEVEL; SODIUM RETENTION; TREATMENT DURATION; TREATMENT PLANNING; WATER DEPRIVATION;

BRAIN EDEMA; BRAIN INJURIES; HUMANS; HYPERNATREMIA; HYPONATREMIA; SODIUM; WATER-ELECTROLYTE BALANCE;

EID: 84865631986     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-012-0284-5     Document Type: Article

References (28)

1. Larive LL, Rhoney DH, Parker Jr D, et al. Introducing hypertonic saline for cerebral edema: an academic center experience. Neurocrit Care. 2004;1(4):435-40. (Pubitemid 41278331)
2. Raslan A, Bhardwaj A. Medical management of cerebral edema. Neurosurg Focus. 2007;22(5):E12.
3. Bhardwaj A. Neurological impact of vasopressin dysregulation and hyponatremia. Ann Neurol. 2006;59:229-36. (Pubitemid 43202475)
4. Bhardwaj A, Ulatowski JA. Hypertonic saline solutions in brain injury. Curr Opin Crit Care. 2004;10:126-31. (Pubitemid 38519721)
5. Androgué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342:1581-9. (Pubitemid 30340505)
6. Bradshaw K, Smith M. Disorders of sodium balance after brain injury.: continuing education in anesthesia. Crit Care Pain. 2008;8 (4):129-33.
7. Paredes-Andrade E, Solid C, Rockswold SB, et al. Hypertonic saline reduces intracranial hypertension in the presence of high serum and cerebrospinal fluid osmolalities. Neurocrit Care. 2011 Jul 2. Epub ahead of print.
8. Adamides AA, Winter CD, Lewis PM, et al. Current controversies in the management of patients with severe traumatic brain injury. ANZ J Surg. 2006;76:163-74.
9. Hays AN, Lazaridis C, Neyens R, et al. Osmotherapy: use among neurointensivists. Neurocrit Care. 2011;14:222-8.
10. Androgue HJ, Madias NE. Hypernatremia. NEJM. 2000;342 (20):1493-9. (Pubitemid 30318274)
11. Antunes-Rodrigues J, de Castro M, Elias LL, et al. Neuroendocrine control of body fluid metabolism. Physiol Rev. 2004;84:169-208. (Pubitemid 38049879)
12. Kim DK, Joo KW. Hyponatremia in patients with neurologic disorders. Electrolyte Blood Press. 2009;7:51-7.
13. Tomasino C. Volume and electrolyte management. Best Pract Res Anesthesiol. 2007;21(4):497-516.
14. Rabinstein AA, Bruder N. Management of hyponatremia and volume contraction. Neurocrit Care. 2011;15(2):354-60.
15. Nathan BR. Cerebral correlates of hyponatremia. Neurocrit Care. 2007;06:72-8. (Pubitemid 46424456)
16. Wright WL, Asbury WH, Gilmore JL, et al. Conivaptan for hyponatremia in the neurocritical care unit. Neurocrit Care. 2009;11 (1):6-13.
17. Sterns RH, Silver SM. Brain volume regulation in response to hypo-osmolality and its correction. Am J Med. 2006;119:S12-6.
18. Sterns RH, Cappuccio JD, Silver SM, et al. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol. 1994;1522.
19. Froelich M, Ni Q, Wess C, et al. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37:1433-41.
20. Parra A: "Hypertonic Saline," adult neurocritical care protocols. Revision 04/01/210. www.universityhealthsystem.com
21. Koenig M. Cerebral edema and intracranial hypertension. In: Bhardwaj A, Mirski MA, editors. Handbook of neurocritical care. 2nd ed. New York: Springer; 211. p. 73-88.
22. Koenig MA, Bryan M, Lewin JL, et al. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70:1023-9. (Pubitemid 351451321)
23. Woo CH, Rao VA, Sheridan W, et al. Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia. Neurocrit Care. 2009;11:22834.
24. Keyrouz SG, Dhar R, Diringer MN. Variation in osmotic response to sustained mannitol administration. Neurocrit Care. 2008;9:204-9.
25. Bardutzky J, Schwab S. Antiedema therapy in ischemic stroke. Stroke. 2007;38:3084-94. (Pubitemid 350035708)
26. Murphy T, Dhar R, Diringer M. Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit. Neurocrit Care. 2009;11(1):14-9.
27. Dhar R, Murphy-Human T. A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury. Neurocrit Care. 2010;14:97-102.
28. NaidechAM, Paparello J, Leibling SM. Use of conivaptan (Vaprisol) for hyponatremic neuro-ICU patients. Neurocrit Care. 2010;13:57-61.